MedPath

Evaluating the changes in outcome and serum metabolic biochemical parameters after oral Simvastatin administration in patients with poly cystic ovary syndrome undergoing IVF

Not Applicable
Conditions
Poly Cystic Ovarian Syndrom.
Sclerocystic ovary syndrome
Registration Number
IRCT2012110811408N1
Lead Sponsor
Vice Chancellor for Research and Technology of Hamadan University of Medical Sciences and Health ser
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

inclusion criteria: All patients in reproductive age with pcos that refer to infertility clinic of fatemieh hospital of Hamadan, that agreed to participate in the study and complete the informed consent, and without history of endocrine disease, Recent use of lipid-lowering drugs and statins.
exclusion criteria: don't referring After getting treatment, arbitrary discontinuation of treatment

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HDL. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.;LDL. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.;TG. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.;Testestroon. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.;GTT. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath